Insulet Corporation (PODD) PT Lowered to $200 at Raymond James
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Price: $157.83 +1.92%
Rating Summary:
22 Buy, 18 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 23 | New: 12
Rating Summary:
22 Buy, 18 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 23 | New: 12
Join SI Premium – FREE
Raymond James analyst Jayson Bedford lowered the price target on Insulet Corporation (NASDAQ: PODD) to $200.00 (from $220.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Insulet (PODD) Tops Q3 EPS by 40c
- Abbvie (ABBV) PT Raised to $315 at Freedom Broker
- Dynatrace Inc. (DT) PT Lowered to $60 at DA Davidson
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
